CDK4/6 inhibitor(palbocilcib) efficacy for head and neck squamous cell carcinoma(HNSCC), including both HPV plus and HPV- cell lines

被引：2
|
作者：
Chen, Jo-Pai [1 ]
Chang, Jui-Ying [1 ]
Hong, Reuy-Long [2 ]
机构：
[1] Natl Taiwan Univ Hosp, Yun Lin Branch, Yunlin, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4408
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
    Bteich, Yara T.
    Hosri, Jad E.
    Wehbi, Jad A.
    Daou, Lea R.
    ECANCERMEDICALSCIENCE, 2022, 16
  • [32] PI3K/AKT/mTOR pathway and CDK4/6 inhibitors efficiently inhibit cell growth of HPV-positive and HPV-negative head and neck squamous cell carcinoma in vitro
    Demers, Imke
    Verhees, Femke
    Leegemaate, Dion
    Jacobs, Robin
    Hoeben, Ann
    Hoebers, Frank
    Kremer, Bernd
    Speel, Ernst-Jan
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma
    Devaraj, K
    Gillison, ML
    Wu, TC
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2003, 14 (05) : 345 - 362
  • [34] NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)
    Topchu, Iuliia
    Pangeni, Rajendra
    Bychkov, Igor
    Makhov, Petr
    Karanicolas, John
    Yu, Jindan
    Golemis, Erica
    Lorch, Jochen
    Boumber, Yanis
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Improved outcomes in HPV plus versus HPV- locally advanced head and neck squamous cell carcinoma (LAH&NSCC) when treated with cetuximab and concurrent radiation
    Howard, M.
    Slack, R.
    Hartmann, D. P.
    Harter, W. A.
    Newkirk, K. A.
    Davidson, B. J.
    Berkowitz, F.
    Steadman, K.
    Lockard, D.
    Deeken, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] The difference of drug sensitivity between HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines
    Zhang, Ming
    Mazumdar, Tuhina
    Peng, Shaohua
    Tong, Pan
    Sambandam, Vaishnavi
    Byers, Lauren A.
    Myers, Jeffrey N.
    Wang, Jing
    Johnson, Faye M.
    CANCER RESEARCH, 2015, 75
  • [37] CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck
    Chuanhao Tang
    Li Lin
    Wei Zhou
    Xiang Liu
    Yali Fu
    Lingling Zhang
    Li Li
    Xiangyi Wang
    Libo Zhao
    Jun Liang
    Chinese Journal of Cancer Research, 2019, 31 (06) : 901 - 909
  • [38] The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
    Ku, Bo Mi
    Yi, Seong Yoon
    Koh, Jiae
    Bae, Yeon-Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    ONCOTARGET, 2016, 7 (12) : 14803 - 14813
  • [39] Combination of CDK4/6 inhibitor, LY2835219, and mTOR inhibitor to synergistically suppress the growth of head and neck squamous cell carcinoma
    Ahn, Myung-Ju
    Ku, Bo Mi
    Yi, Seong Yoon
    Koh, Jiae
    Bae, Yeon-Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors
    Matthias Lechner
    Garrett M Frampton
    Tim Fenton
    Andrew Feber
    Gary Palmer
    Amrita Jay
    Nischalan Pillay
    Martin Forster
    Maureen T Cronin
    Doron Lipson
    Vincent A Miller
    Timothy A Brennan
    Stephen Henderson
    Francis Vaz
    Paul O'Flynn
    Nicholas Kalavrezos
    Roman Yelensky
    Stephan Beck
    Philip J Stephens
    Chris Boshoff
    Genome Medicine, 5
12345